Jacobson Pharma's (HKG:2633) attributable profit rose to HK$267 million, or HK$0.139 per share, in the year ended March 31, from HK$251 million, or HK$0.1313 per share in the year-ago period, according to a Thursday filing with the Hong Kong Stock Exchange.
Revenue at the pharmaceutical company grew to HK$1.47 billion from HK$1.27 billion a year earlier, the filing said.
The company declared a final dividend of HK$0.03 per share, payable Oct. 4 to shareholders on record as of Sept. 6.
Shares slid nearly 2% in Hong Kong on midday Friday.
Price (HKD): $0.63, Change: $-0.01, Percent Change: -1.56%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments